Stress, hypercortisolism and corticosteroid receptors in depression: Implicatons for therapy

Journal of Affective Disorders

Volumn 62, Issue 1-2, 2001, Pages 77-91

  Holsboer, Florian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Antidepressants; Corticotropin releasing hormone; Depression; HPA system; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; ARGIPRESSIN; BIOGENIC AMINE; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOSTEROID RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DEXAMETHASONE; HORMONE RECEPTOR BLOCKING AGENT; HYDROCORTISONE; LIGAND; MESSENGER RNA; NEUROHORMONE; TRANSCRIPTION FACTOR;

ARTICLE; DEPRESSION; DISEASE COURSE; DOSE RESPONSE; HORMONAL REGULATION; HUMAN; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; STRESS;

EID: 0035153486     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00352-9     Document Type: Review

References (32)

1. Brain corticosteroid receptor balance in health and disease
2. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
3. Pituitary-adrenal system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and in normal comparison subjects
4. Repeated dexamethasone suppression test during depressive illness
5. Human corticotropin-releasing hormone in depression
6. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders
7. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
8. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
9. Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment - Neurobiological and psychometric assessment of course
10. 2 receptor antisense oligonucleotides into the rat brain
11. Corticosteroid receptor function is decreased in depressed patients
12. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders
13. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function
14. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
15. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims
16. Treatment of major depression with metyrapone and hydrocortisone
17. The physiology and pharmacology of corticotropin-releasing factor
18. The neurosteroid tetrahydroprogesterone counteracts CRH-induced anxiety and alters the release and gene expression of CRH in the rat hypothalamus
19. Increased number of vasopressin-and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression
20. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients
21. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide
22. Neuroactive steroids: Mechanisms of action and neuropsychopharmacological perspectives
23. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
24. Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
25. Identification and characterization of a 3′,5′-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter
26. Overproduction of corticotropin-releasing factor in transgenic mice: A genetic model of anxiogenic behavior
27. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
28. Heterodimerization between mineralocorticoid and glucocorticoid receptor: A new principle of glucocorticoid action in the CNS
29. Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects
30. Cortisol response to the combined dexamethasone-CRH test predicts medium-term outcome in patients with remitted depression
31. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated
32. Cortisol response in the combined dexamethaone-CRH test as relapse predictor in patients with remitted depression: A prospective study